ibrutinib,zanubrutinib
beigene,janssen,Abbvie
['alpine']
following her presentation at #ash22, jennifer brown, md, phd spoke about her results from the phase 3 alpine study. 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090